US Top Rating Updates on 10/4: POSH, GILD, BK, PARA and More

Analysts Notebook wrote a column · Oct 4, 2022 08:05

Upgrades

• $Credicorp(BAP.US)$ : Citigroup Upgrades to Buy from Neutral - PT $161 (from $128)

• $Bank of New York Mellon(BK.US)$ : Citigroup Upgrades to Buy from Neutral

• $CommScope(COMM.US)$ : Credit Suisse Upgrades to Outperform from Neutral - PT $17 (from $11)

• $Domino's Pizza(DPZ.US)$ : UBS Upgrades to Buy from Neutral - PT $385 (from $430)

• $Gilead Sciences(GILD.US)$ : JPMorgan Upgrades to Overweight from Neutral - PT $80 (from $72)

Downgrades

• $Applied Genetic(AGTC.US)$ : Wells Fargo Downgrades to Equal Weight from Overweight - PT $12

• $F45 Training(FXLV.US)$ : JPMorgan Downgrades to Neutral from Overweight

• $M&T Bank(MTB.US)$ : Citigroup Downgrades to Neutral from Buy - PT $200

• $Paramount Global-B(PARA.US)$ : Wells Fargo Downgrades to Equal Weight from Overweight - PT $19 (from $40)

• $Poshmark(POSH.US)$ : Wedbush Downgrades to Neutral From Outperform - PT $17.5 (from $14)

Coverage Initiated

• $Butterfly Network(BFLY.US)$ : B.Riley initiates at Buy - PT $9.50

• $Bolt Biotherapeutics(BOLT.US)$ : H.C. Wainwright initiates at Buy - PT $8

• $Bowlero(BOWL.US)$ : Oppenheimer initiates at Outperform - PT $16

• $Core Scientific(CORZ.US)$ : Barclays initiates at Overweight - PT $3

• $Ginkgo Bioworks(DNA.US)$ : Morgan Stanley initiates at Equalweight - PT $5

\Disclaimer: The content should not be relied on as advice or recommendation.

Disclaimer: Moomoo Technologies Inc. is providing this content for information and educational use only. Read more

Translate

Report

136K Views

Comment

Moomoo News Official Account

How do analysts evaluate the market?

15KFollowers

8Following

35KVisitors